Tag: Pharmaceutical Innovation

Research: Dual-Targeting Strategy Shows Promise in Halting Melanoma Metastasis by Disrupting the Extracellular Matrix

New research reveals a dual-targeting approach that inhibits LOX and HSP70 — key drivers of extracellular matrix remodeling — to suppress melanoma metastasis and enhance immunotherapy response.